Schonfeld Strategic Advisors LLC Cytokinetics Inc Transaction History

Schonfeld Strategic Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$47.86 - $75.05 $1.14 Million - $1.79 Million	-23,915 Reduced 60.37%	15,699 $850,000
Q1 2024 May 15, 2024	BUY	$63.75 - $108.06 $2.27 Million - $3.85 Million	35,650 Added 899.34%	39,614 $2.78 Million
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $266,568 - $827,970	-9,917 Reduced 71.44%	3,964 $330,000
Q3 2023 Nov 14, 2023	SELL	$29.46 - $36.61 $498,934 - $620,026	-16,936 Reduced 54.96%	13,881 $408,000
Q2 2023 Aug 14, 2023	BUY	$32.62 - $40.75 $110,353 - $137,857	3,383 Added 12.33%	30,817 $1.01 Million
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $981,684 - $1.35 Million	-29,427 Reduced 51.75%	27,434 $965,000
Q4 2022 Feb 14, 2023	BUY	$35.77 - $51.11 $2.03 Million - $2.91 Million	56,861 New	56,861 $2.61 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $2.41 Million - $3.48 Million	71,166 Added 867.88%	79,366 $3.12 Million
Q1 2022 May 16, 2022	SELL	$29.74 - $46.0 $2.78 Million - $4.3 Million	-93,500 Reduced 91.94%	8,200 $302,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $762,020 - $1.03 Million	22,184 Added 27.9%	101,700 $4.64 Million
Q3 2021 Nov 16, 2021	BUY	$18.54 - $35.74 $1.1 Million - $2.12 Million	59,216 Added 291.7%	79,516 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $401,737 - $547,897	20,300 New	20,300 $402,000
Q2 2020 Aug 14, 2020	SELL	$11.15 - $24.64 $147,882 - $326,800	-13,263 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.75 - $16.3 $116,051 - $216,186	13,263 New	13,263 $156,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.62B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.